Dr Joss Adams
MA, MB, BChir, MRCP, FRCR
Dr Adams trained at St John's College, Cambridge from 1990 to 1995. He completed his junior medical training in Oxford. He undertook specialist training in clinical oncology in Oxford from 2001 to 2006. He has been a Consultant in Reading since 2006.
Dr Adams is the principal investigator for clinical trials in lung and breast cancer at the Royal Berkshire Hospital, Reading.
He was the Clinical Governance Lead at the Berkshire Cancer Centre, within the Royal Berkshire Hospital, Reading between 2006 and 2011. He was the Clinical Lead for Chemotherapy at the centre between 2011 and 2017.
He is the Clinical Supervisor for specialist oncology trainees.
He has written chapters for the Oxford Handbook of Emergencies in Oncology and Problem Solving in Oncology.
COVID-19 testing or antibody tests are not available as a standalone service at Spire Dunedin Hospital.
MA, MB BChir / St John's College, Cambridge / 1995
Master of Arts, Bachelor of Medicine
A Phase II, randomised, open-label study of Gemcitabine/Carboplatin first-line chemotherapy in combination with or without the antisense oligonucleotide Apatorsen (OGX-427) in advanced squamous cell lung cancers ESMO 2017
Addition of Apatorsen, an inhibitor of Hsp27, to first-line gemcitabine/carboplatin in advanced squamous cell lung cancer: Design of the Cedar Study. ASCO 2016
2017: Nominated for national Oncology Registrars' Forum Trainer Award.
2014: Cycled from Reading to Barcelona on a tandem with Nurse Consultant Mark Foulkes on a charity cycle ride to raise funds to facilitate the local delivery of chemotherapy for patients in West Berkshire.